Nanosphere, Inc.

169 articles about Nanosphere, Inc.

• 

  10 Reasons to Keep an Eye on Chicago Biotech in 2023

  10/18/2022

  Between top-notch academic institutions, solid venture capital funding, expanding lab space and governmental support, Chicago is emerging as a true hotbed for biotech growth.

• NanoSphere Forms Strategic Partnership to Launch Evolve Products in Mexico

  12/10/2018

  Agreement will bring the patented NanoSphere Delivery System™ to an emerging $5 billion cannabis market

• NanoSphere Develops New Product Eliminating Need to Smoke Cannabis

  11/26/2018

  NanoSphere Health Sciences Inc. is pleased to announce the Company has developed a new intraoral delivered cannabis product for the Canadian market, which produces similar effects to smoking cannabis, but is safer and more effective than edibles.

• Evolve Formulas Transdermal NanoSerum™ CBD Met with Unprecedented Response across Colorado Market

  11/7/2018

  Industry-First Formulation Harnesses the Anti-Inflammatory Qualities of CBD and Antioxidant Power of Resveratrol for Maximum Wellness Benefits

• NanoSphere Health Sciences and Vertical Companies™ Commence Production in California

  10/10/2018

  Award-Winning Evolve Formulas Transdermal NanoSerum™ To Hit Dispensary Shelves in the Golden State in Time for the Holidays

• NanoSphere Health Sciences Expands to Indiana With Evolve Formulas NanoSerum™ Hemp

  9/11/2018

  Evolve Formulas Introduces New Hemp-Derived Product to Indiana Market, Launching in Mid-September

• NanoSphere Health Sciences Partners with Delta 9 for Canadian Expansion

  7/31/2018

  Biotech Leader's Cannabis Division, Evolve Formulas, Prepares to Launch in Canadian Market

• NanoSphere Health Sciences' Brand Evolve Formulas Expanding Rapidly Across Colorado and Beyond

  7/11/2018

  Next-Generation Cannabis Products Now Available in Over 200 Colorado Dispensaries, with Production Beginning in the California Market

• CBD Naturals®' and NanoSphere™ Technologies Launch Strategic Partnership

  6/13/2018

  CBD Naturals® and NanoSphere™ Technologies have announced a strategic partnership designed to develop more nano-products.

• Dr. Michele Ross, Leading Cannabis Voice, Joins NanoSphere Health Sciences Team

  6/7/2018

  Dr. Michele Ross has joined the advisory board for NanoSphere Health Sciences, LLC

• NanoSphere Health Sciences Retains Gravitas Securities and Grant Options

  5/24/2018

  Biotechnology leader NanoSphere Health Sciences, LLC (CSE: NSHS) (OTC: NSHSF) has retained the services of Gravitas Securities Inc. ("Gravitas") to act as financial advisors to the company. NanoSphere also wishes to announce that it has granted 3,165,555 options to directors, officers and consultants of the company at a price of $0.65.

• NanoSphere Health Sciences Awarded Breakthrough Patent for Disruptive Nanoparticle Delivery Platform

  3/27/2018

  Landmark patent marks most significant advancement in over 25 years for non-invasive medical delivery systems

• NanoSphere Health Sciences Announces Name Change, CSE Listing and Conversion of %5.9M in Subscription Receipts

  12/5/2017

  NanoSphere's shares will commence trading tomorrow, December 5, 2017, under the symbol "NSHS".

• Corazon and NanoSphere Announce Completion of $5.9M Financing and Merger

  12/1/2017

  Based upon the CSE's conditional listing approval, the Company will make its final submission for CSE listing in short order, and concurrently with its listing on the CSE will change its name to "NanoSphere Health Sciences Inc." and effect a de-listing from the TSX Venture Exchange.

• Nanosphere Signs Binding Merger Agreement For 100% Acquisition By Corazon Gold Corp.

  6/20/2017

• Luminex Completes Acquisition Of Nanosphere

  6/30/2016

• Luminex Announces Commencement Of Tender Offer For All Outstanding Shares Of Nanosphere Common Stock

  6/2/2016

• Luminex Sweetens Nanosphere Bid to $102 Million

  5/23/2016

• Nanosphere Announces First Quarter Results

  5/16/2016

• Luminex Snaps Up Nanosphere for $56 Million

  5/16/2016